See news from the full history of Samplix, covering all the conferences we've attended, new product launches, and more.
The Festival of Genomics and Biodata is the UK's largest genomics event. This year, the organizers decided to have the event in a virtual format due to the COVID-19 pandemic. Samplix fully supported their decision and took an active part in the event as a sponsor and exhibitor.
Dr. Lydia Teboul of MRC Harwell Institute spoke about her team's use of the Xdrop target enrichment workflow to map and characterize mouse transgenes. See Dr. Teboul's talk
Our CTO, Dr. Marie Just Mikkelsen, gave a lightning talk on how microfluidics technology is revolutionizing gene and cell screening. See Dr. Mikkelsen's talk
To facilitate the handling of Oxford Nanopore Technologies and Illumina data from Xdrop workflows, Samplix has launched a suite of dedicated bioinformatics tools that are free to use for our customers.
The suite includes tools for:
The SLAS Europe 2022 Conference is an important networking opportunity for people involved in lab automation and all the areas it relates to, including early drug discovery, cell biology, and molecular engineering. It was held at the RDS in Dublin from May 25–27.
We were delighted to be there, taking part as an exhibitor (at Booth K1, as pictured) and as a presenter. Our CTO, Dr. Marie Mikkelsen, gave an important talk presenting some of our latest results from functional analyses of mammalian cells encapsulated in our new DE50 droplets.
The organizers of the International Plant and Animal Genome XXIX took the difficult decision to move the conference to a virtual platform. Samplix supported their decision and wished the organizers and attendees an excellent experience. We're looking forward to next year's conference and exhibition.
November 16-18
The second international conference on Microbial Food and Feed Ingredients (MiFFI) was in Copenhagen. Samplix experts were at Booth C2 to answer questions and demonstrate how microfluidics technology can boost the resolution and throughput of single-cell investigations and synthetic biology workflows.
November 5, 2021
Our experts were on hand to discuss how Xdrop technology can integrate into your genomics and metagenomics workflows, boosting the resolution of long- and short-read sequencing. It was a great opportunity to find out how our instrument and services can support research.
We also sponsored a talk by Dr. Claudia Kutter of the Karolinska Institute on multiomics data and CRISPR editing.
In the agenda:
September 7, 2021
Austin Garner from Harvard University and Robert Heal from the Sainsbury Laboratory presented how they gain high-resolution insights into complex plant genomes. Austin studies the genetic underpinnings of speciation, using Samplix's Xdrop to sequence relevant long stretches of the Phlox drummondii 6-gigabase genome. Robert investigates genes that boost plant resistance to pathogens, using Xdrop to assemble complex gene clusters with the goal of cloning novel resistance genes to develop blight-resistant potato varieties.
August 28, 2021
Dr. Adam Ameur presented a first-time application of droplet multiple displacement amplification followed by long-read sequencing to examine the genomic architecture of a single human cell.
June 29, 2021
May 25, 2021
The following topics were presented:
April 20, 2021
May 30, 2021
In the agenda: Validation of Genome Editing through Indirect Sequence Capture and Long-Read Sequencing. Presented by Peter Mouritzen, Vice President Application and Market Development, Samplix
March 11-12
Parallel Session 2: Long reads
March 4, 2021
The webinar included the following talks:
January 26-29
In the agenda: CRISPR Validation and Resolving Complex Genomics Landscapes with Xdrop presented by Peter Mouritzen, Vice President Application and Market Development, Samplix
December 17-18
In the agenda: Xdrop Technology for targeted enrichment of genomic regions for long- and short-read sequencing. Presented by Peter Mouritzen, Vice President Application and Market Development, Samplix
December 1-3
In the agenda: A pivotal contribution to CRISPR-editing validation. Presented by Cristina Gamba, Global Product Manager, Samplix
November 19-20
In the agenda: Discover Xdrop: Whole Genome Amplification (WGA) in droplets for single cells. Presented by Peter Mouritzen, Vice President Application and Market Development, Samplix
November 5-6
The conference included the following talks:
October 1, 2020
Samplix has launched a new CRISPR validation service using its Xdrop platform. This proprietary technology from Samplix can enrich genomic regions longer than 100 kb from as little as 1 ng genomic DNA and with single-molecule resolution.
To read more, please see the full press release here.
We have received an overwhelming number of very high quality applications, so we decided to award 4 grants instead of 3. All applications have been carefully reviewed by a team of 5 Samplix scientists.
June 30, 2020
The webinar had the following program:
PART 1: Tackling Disease-Related Repeat-Expansion Analysis. Presented by Marzia Rossato, Researcher, Functional Genomic Lab, University of Verona
PART 2: Validation of CRISPR in a 100 kb Region Surrounding the Editing Site. Presented by Peter Mouritzen, Vice President Application and Market Development, Samplix
PART 3: The Launch of a Grant Program and Q&A
May 28, 2020
Bioneer provides customized gene editing services including advanced quality control of gene edited cell models and will through their partnership with Samplix offer their customers access to the Xdrop technology.
Learn more: Bioneer and CRISPR Editing Verification.
May 5, 2020
Today, Samplix launched its comprehensive service program to grant any laboratory access to the advantages of Xdrop technology.
To read more, please see the full press release here:
June 6-9
We attended at 2020's European Society for Human Genetics (ESHG) Conference in Berlin.
During ESHG, we presented our Xdrop instrument.
March 12, 2020
Samplix attended and presented at the Genome Editing 2020 conference, in Oxford. Our speaker, Peter Mouritzen, Vice President Application and Market Development at Samplix, presented the following: Xdrop – A New Microfluidics Technology for the Analysis of CRISPR Editing.
March 4-5
Samplix demonstrated our recently launched Xdrop system at the 8th Plant and Gene Editing Congress in Rotterdam, Netherlands.
4-6 November
Samplix demonstrated our recently launched Xdrop system at the EMBL Heidelberg Cancer Genomics 2019 conference in Heidelberg, Germany.
November 7-8
Samplix demonstrated our recently launched Xdrop system at the Oxford Global 11th Annual NGS & Clinical Diagnostics Congress in London, UK.
November 13-14
We attended at the Genomic Medicine 2019 Nordic conference at Kennedy Center at Rigshospitalet in Copenhagen, Denmark.
November 20-21
We attended at the Genomic Medicine 2019 Cambridge conference at Murray Edwards College in Cambridge, UK.
September 2, 2019
Today, Samplix happily announced the commercial launch of our Xdrop instrument for the targeted enrichment of long genomic regions from as little as 1 ng of DNA.
Scientists in the genomics field can now routinely capture up to 100 kb long genomic regions, based upon very limited target sequence information (100-200 bp of sequence). Using Xdrop technology together with long- or short-read sequencers makes it possible to sequence into regions that were previously inaccessible.
The types of genomic regions that are now unlocked by the Xdrop technology include:
Today, Samplix announced the commercial launch of its Xdrop sample preparation products for PCR-free target enrichment yet maintaining PCR-level specificity.
January 2019. Samplix is pleased to announce that the company was selected by the European Commission among the winners of the prestigious Horizon 2020 – SME Instrument program, obtaining €1.9 million to mature its proprietary Xdrop technology. The selection process was highly competitive with more than 1.800 applicants and a success rate of only about 3%.
Samplix’ proprietary Xdrop technology comprises novel microfluidics, chemistry and bioinformatics in a simple work process that allows scientists and clinicians to partition millions of single molecules in droplets, thereby enabling both targeted enrichment and high-quality amplification of single molecules for sequencing analysis.
The Xdrop technology is currently in beta test at leading research institutions world-wide.
“We are excited to receive recognition and support by the European Commission for completion of our product development towards commercial launch of the Xdrop solution later this year” said CEO Lars Kongsbak.
To read more about Horizon 2020 SME awards, please visit European Commission website:
